Interactions Between HIV and SIV with DC-SIGN & DC-SIGNR

HIV 和 SIV 与 DC-SIGN 之间的相互作用

基本信息

  • 批准号:
    6450955
  • 负责人:
  • 金额:
    $ 35.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-09-30 至 2006-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION:(provided by applicant)The entry of HIV-1 into cells requires interactions between the viral Env protein, CD4 and a coreceptor. While binding to CD4 is required for efficient virus infection, attachment of virus to the cell surface can be mediated by interactions with a variety of molecules, only some of which have been well characterized. Attachment to the cell surface per se can be a limiting step in the entry pathway. In vitro, infection of cell lines and PBMC by HIV-1 can be enhanced by inclusion of polycations in the virus inoculum or by centrifuging virus onto the cell surface. Infection of activated T-cells can also be enhanced by first binding HIV-1 to dendritic cells (DCs). After removing unbound virus, addition of activated T cells results in very efficient transmission of virus to these cellular targets. Recently, a type lI integral membrane protein termed DC-SIGN has been shown to mediate binding of HIV-1 to DCs. DC-SIGN contains a C-type (i.e. calcium-dependent) lectin domain that mediates this process. Because DCs migrate from peripheral mucosal tissues to lymph nodes, it has been proposed that HIV uses DCs as carriers, allowing the virus to access lymphoid tissue. More generally, the discovery of DC-SIGN raises the possibility that other highly specific virus attachment factors exist. Indeed, we have found that DC-SIGNR, which shares 77 percent amino acid identity with DC-SIGN, also supports HIV binding and transmission. DC-SIGNR is expressed on endothelial cells in lymph nodes, liver, and the placenta, while DC-SIGN is expressed on DCs and some types of macrophages in vivo. The ability of DC-SIGN and DC-SIGNR to bind virus with high affinity, to augment lymphocyte infection, and their expression on cells in mucosal surfaces and the placenta where transmission occurs leads us to hypothesize that these proteins facilitate viral binding to cells, and that once bound, virions are modified and/or protected, and ultimately presented more efficiently to key target cells that initiate viral propagation and dissemination in the host. In this proposal, we will pursue four Specific Aims that will explore the structure, function, and expression patterns of DC- SIGN and DC-SIGNR. Furthermore, we will develop reagents that will enable us to test the role of DC-SIGN in sexual transmission of virus using the rhesus macaque model. We propose to take a highly collaborative approach employing the skills and expertise of the Doms and Hoxie labs, as well as collaborations with other laboratories so that these questions can be addressed quickly and efficiently through the pursuit of 4 Specific Aims.
描述:(由申请人提供)HIV-1进入细胞需要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert W. Doms其他文献

HIV entry: are all receptors created equal?
HIV 进入:所有受体都是平等产生的吗?
  • DOI:
    10.1038/ni819
  • 发表时间:
    2002-07-01
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Mark A. Goldsmith;Robert W. Doms
  • 通讯作者:
    Robert W. Doms
Regulation of protein export from the endoplasmic reticulum.
内质网蛋白质输出的调节。
Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
阿尔茨海默病 Aβ(1–42) 在 NT2N 细胞的内质网/中间区室中生成。
  • DOI:
    10.1038/nm0997-1021
  • 发表时间:
    1997-09-01
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    David G. Cook;Mark S. Forman;Jane C. Sung;Susan Leight;Dennis L. Kolson;Takeshi Iwatsubo;Virgina M.-Y. Lee;Robert W. Doms
  • 通讯作者:
    Robert W. Doms
Chemokines and coreceptors in HIV/SIV-host interactions.
HIV/SIV-宿主相互作用中的趋化因子和辅助受体。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T. L. Hoffman;Robert W. Doms
  • 通讯作者:
    Robert W. Doms

Robert W. Doms的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert W. Doms', 18)}}的其他基金

Interactions of Emerging Bunyaviruses with Host Cells
新兴布尼亚病毒与宿主细胞的相互作用
  • 批准号:
    8233375
  • 财政年份:
    2011
  • 资助金额:
    $ 35.66万
  • 项目类别:
Interactions of Emerging Bunyaviruses with Host Cells
新兴布尼亚病毒与宿主细胞的相互作用
  • 批准号:
    7670061
  • 财政年份:
    2009
  • 资助金额:
    $ 35.66万
  • 项目类别:
Finger Nucleases to Specifically Disrupt Coreceptor Expression
特异性破坏辅助受体表达的指状核酸酶
  • 批准号:
    7668215
  • 财政年份:
    2009
  • 资助金额:
    $ 35.66万
  • 项目类别:
Crimean congo hemorrhagic fever virus glycoproteins
克里米亚刚果出血热病毒糖蛋白
  • 批准号:
    6856987
  • 财政年份:
    2005
  • 资助金额:
    $ 35.66万
  • 项目类别:
Crimean congo hemorrhagic fever virus glycoproteins
克里米亚刚果出血热病毒糖蛋白
  • 批准号:
    7028300
  • 财政年份:
    2005
  • 资助金额:
    $ 35.66万
  • 项目类别:
Training in Emerging Infectious Diseases
新发传染病培训
  • 批准号:
    7266185
  • 财政年份:
    2003
  • 资助金额:
    $ 35.66万
  • 项目类别:
Training in emerging infectious diseases
新发传染病培训
  • 批准号:
    7504391
  • 财政年份:
    2003
  • 资助金额:
    $ 35.66万
  • 项目类别:
Training in Emerging Infectious Diseases
新发传染病培训
  • 批准号:
    6915028
  • 财政年份:
    2003
  • 资助金额:
    $ 35.66万
  • 项目类别:
Training in emerging infectious diseases
新发传染病培训
  • 批准号:
    8079046
  • 财政年份:
    2003
  • 资助金额:
    $ 35.66万
  • 项目类别:
Training in emerging infectious diseases
新发传染病培训
  • 批准号:
    8301668
  • 财政年份:
    2003
  • 资助金额:
    $ 35.66万
  • 项目类别:

相似海外基金

PROTEIN X-RAY CRYSTALLOGRAPHY: HIV ENVELOPE PROTEIN
蛋白质 X 射线晶体学:HIV 包膜蛋白
  • 批准号:
    7369566
  • 财政年份:
    2005
  • 资助金额:
    $ 35.66万
  • 项目类别:
PAIN FACILITATION BY GP120 AND HIV ENVELOPE PROTEIN
GP120 和 HIV 包膜蛋白促进疼痛
  • 批准号:
    6540025
  • 财政年份:
    1999
  • 资助金额:
    $ 35.66万
  • 项目类别:
PAIN FACILITATION BY GP120 AND HIV ENVELOPE PROTEIN
GP120 和 HIV 包膜蛋白促进疼痛
  • 批准号:
    6188002
  • 财政年份:
    1999
  • 资助金额:
    $ 35.66万
  • 项目类别:
PAIN FACILITATION BY GP120 AND HIV ENVELOPE PROTEIN
GP120 和 HIV 包膜蛋白促进疼痛
  • 批准号:
    2907163
  • 财政年份:
    1999
  • 资助金额:
    $ 35.66万
  • 项目类别:
PAIN FACILITATION BY GP120 AND HIV ENVELOPE PROTEIN
GP120 和 HIV 包膜蛋白促进疼痛
  • 批准号:
    6612844
  • 财政年份:
    1999
  • 资助金额:
    $ 35.66万
  • 项目类别:
PAIN FACILITATION BY GP120 AND HIV ENVELOPE PROTEIN
GP120 和 HIV 包膜蛋白促进疼痛
  • 批准号:
    6394025
  • 财政年份:
    1999
  • 资助金额:
    $ 35.66万
  • 项目类别:
PAIN FACILITATION BY GP120 AND HIV ENVELOPE PROTEIN
GP120 和 HIV 包膜蛋白促进疼痛
  • 批准号:
    6559805
  • 财政年份:
    1999
  • 资助金额:
    $ 35.66万
  • 项目类别:
PAIN FACILITATION BY GP120 AND HIV ENVELOPE PROTEIN
GP120 和 HIV 包膜蛋白促进疼痛
  • 批准号:
    6211668
  • 财政年份:
    1999
  • 资助金额:
    $ 35.66万
  • 项目类别:
Influence of HIV envelope protein oligomerization on interactions with chemokine receptors.
HIV 包膜蛋白寡聚化对与趋化因子受体相互作用的影响。
  • 批准号:
    nhmrc : 987004
  • 财政年份:
    1998
  • 资助金额:
    $ 35.66万
  • 项目类别:
    CARG - People
Antiviral agents that disrupt the HIV envelope protein function
破坏 HIV 包膜蛋白功能的抗病毒药物
  • 批准号:
    nhmrc : 956047
  • 财政年份:
    1995
  • 资助金额:
    $ 35.66万
  • 项目类别:
    CARG - Research
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了